Teladoc Health, Inc. (4LL.F)
EUR 6.48
(1.54%)
EUR 6.48
(1.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.6 Billion | 2.4 Billion | 2.03 Billion | 1.09 Billion | 553.3 Million | 417.9 Million |
| Cost of Revenue | 760.03 Million | 743.98 Million | 650.25 Million | 390.82 Million | 184.46 Million | 128.73 Million |
| Gross Profit | 1.84 Billion | 1.66 Billion | 1.38 Billion | 703.13 Million | 368.84 Million | 289.17 Million |
| Operating Expenses | 2.09 Billion | 1.89 Billion | 1.62 Billion | 1.12 Billion | 442.66 Million | 355.13 Million |
| Selling, General and Administrative Expenses | 1.36 Billion | 1.3 Billion | 1.1 Billion | 886.88 Million | 339.06 Million | 263.04 Million |
| Research and Development Expenses | 348.52 Million | 333.62 Million | 311.88 Million | 164.94 Million | 64.64 Million | 54.37 Million |
| Other Expenses | 375.12 Million | -859 Thousand | 5.08 Million | -545 Thousand | 342 Thousand | - |
| Cost and Expenses | 2.85 Billion | 2.63 Billion | 2.27 Billion | 1.51 Billion | 627.12 Million | 483.87 Million |
| Operating Income | -248.55 Million | -13.65 Billion | -265.63 Million | -506.42 Million | -80.44 Million | -70.85 Million |
| Interest Expense | 22.28 Million | 9.27 Million | 80.36 Million | 60.49 Million | 29.01 Million | 26.11 Million |
| Income Tax Expense | 760 Thousand | -3.81 Million | 44.13 Million | -90.85 Million | -10.59 Million | 118 Thousand |
| Earnings before Tax | -219.6 Million | -13.66 Billion | -384.65 Million | -575.99 Million | -109.45 Million | -96.96 Million |
| Net Income | -220.36 Million | -13.65 Billion | -428.79 Million | -485.13 Million | -98.86 Million | -97.08 Million |
| Earnings Per Share Basic | -1.36 | -84.60 | -2.73 | -5.36 | -1.38 | -1.47 |
| Earnings Per Share Diluted | -1.36 | -84.60 | -2.73 | -5.36 | -1.38 | -1.47 |
| Weighted Average Shares Outstanding | 162.16 Million | 161.45 Million | 156.93 Million | 90.5 Million | 71.84 Million | 65.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 162.16 Million | 161.45 Million | 156.93 Million | 90.5 Million | 71.84 Million | 65.84 Million |
| Gross Margin | 0.71 | 0.69 | 0.68 | 0.64 | 0.67 | 0.69 |
| EBIT Margin | 0.06 | 5.60 | -0.01 | -0.31 | -0.05 | -0.07 |
| Profit Margin | -0.08 | -5.68 | -0.21 | -0.44 | -0.18 | -0.23 |
| EBITDA | 153.99 Million | -13.37 Billion | -83.89 Million | -437.95 Million | -35.14 Million | -35.25 Million |
| Earnings Before Tax Margin | -0.10 | -5.67 | -0.13 | -0.46 | -0.15 | -0.17 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 642.44 Million | 646.13 Million | 2.6 Billion | 660.52 Million | 660.23 Million | 652.4 Million |
| Cost of Revenue | 188.05 Million | 194.53 Million | 760.03 Million | 193.42 Million | 185.96 Million | 190.54 Million |
| Gross Profit | 454.38 Million | 451.59 Million | 1.84 Billion | 467.1 Million | 474.27 Million | 461.86 Million |
| Operating Expenses | 503.57 Million | 528.66 Million | 2.05 Billion | 497.02 Million | 532.76 Million | 520.9 Million |
| Selling, General and Administrative Expenses | 330.26 Million | 349.39 Million | - | 309.56 Million | 354.17 Million | 358.12 Million |
| Research and Development Expenses | 76.75 Million | 81.38 Million | - | 89.93 Million | 84.28 Million | 87.3 Million |
| Other Expenses | -563 Thousand | -370 Thousand | 4.44 Million | 1.53 Million | -1.79 Million | -207 Thousand |
| Cost and Expenses | 691.63 Million | 723.2 Million | 2.81 Billion | 690.44 Million | 718.72 Million | 711.44 Million |
| Operating Income | -841.14 Million | -87.12 Million | -248.55 Million | -35.08 Million | -64.72 Million | -71.64 Million |
| Interest Expense | 5.64 Million | 5.64 Million | 22.28 Million | 5.53 Million | 5.64 Million | 5.83 Million |
| Income Tax Expense | 3.88 Million | 2.69 Million | 760 Thousand | 3.51 Million | -2.48 Million | -952 Thousand |
| Earnings before Tax | -833.78 Million | -79.19 Million | -219.6 Million | -25.37 Million | -59.55 Million | -66.12 Million |
| Net Income | -837.67 Million | -81.88 Million | -220.36 Million | -28.89 Million | -57.07 Million | -65.17 Million |
| Earnings Per Share Basic | -4.92 | -0.49 | - | -0.17 | -0.35 | -0.40 |
| Earnings Per Share Diluted | -4.92 | -0.49 | - | -0.17 | -0.35 | -0.40 |
| Weighted Average Shares Outstanding | 170.22 Million | 167.73 Million | 162.16 Million | 166.05 Million | 165.11 Million | 164.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 170.22 Million | 167.73 Million | 162.16 Million | 166.05 Million | 165.11 Million | 164.17 Million |
| Gross Margin | 0.71 | 0.70 | 0.71 | 0.71 | 0.72 | 0.71 |
| EBIT Margin | 0.10 | 0.06 | - | 0.13 | 0.08 | 0.05 |
| Profit Margin | -1.30 | -0.13 | -0.08 | -0.04 | -0.09 | -0.10 |
| EBITDA | 62.67 Million | 37 Million | - | 86.8 Million | 49.81 Million | 31.14 Million |
| Earnings Before Tax Margin | -1.31 | -0.13 | -0.10 | -0.05 | -0.10 | -0.11 |
600979
PMEDF
4348
GFIN
9136
NAGTECH